Corporate News
Senores Pharmaceuticals Limited announced several corporate actions, including the appointment of Dr. Viranchi Arvindbhai Shah as an independent director, bringing extensive experience in pharmaceuticals, government policy, and education to the board. The company also approved the Senores Pharmaceuticals Employee Stock Option Scheme 2026, granting 4,72,000 options, representing 1% of the company's equity, to eligible employees with a potential discount of up to 50% on the market price. Furthermore, Senores Pharmaceuticals is planning to incorporate a wholly-owned subsidiary in Mexico and a subsidiary company in Canada, with investments of 100% and 51% or more respectively, to expand its presence in those markets, pending regulatory approvals.